TrialNature cancer2020

Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets.

Nina Bhardwaj et al.PubMed ↗Publisher ↗

No numbers read from the abstract.